1 |
Al-Hajj M, Clarke MF (2004). Self-renewal and solid tumor stem cells. Oncogene, 23, 7274-82.
DOI
|
2 |
Arsura M and Cavin LG (2005). Nuclear factor-kappaB and liver carcinogenesis. Cancer Lett, 229, 157-69.
DOI
|
3 |
Kang JS, Wanibuchi H, Morimura K, et al (2007). Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo. Cancer Res, 67, 11141-6.
DOI
|
4 |
Kenyon J, Gerson SL (2007). The role of DNA damage repair in aging of adult stem cells. Nucleic Acids Res, 35, 7557-65.
DOI
|
5 |
Litvinov SV, Velders MP, Bakker HA, et al (1994). Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule. J Cell Biol, 125, 437-46.
DOI
|
6 |
Maetzel D, Denzel S, Mack B, et al (2009). Nuclear signalling by tumour-associated antigen EpCAM. Nat Cell Biol, 11, 162-71.
DOI
|
7 |
Peto R, Gray R, Brantom P, et al (1991). Effects on 4080 rats of chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine: a detailed dose-response study. Cancer Res, 51, 6415-51.
|
8 |
Pitot HC, Dragan YP, Teeguarden J, et al (1996). Quantitation of multistage carcinogenesis in rat liver. Toxicol Pathol, 24, 119-128.
DOI
|
9 |
Sell S and Dunsford HA (1989). Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am J Pathol, 134, 1347-63.
|
10 |
Turner R, Lozoya O, Wang Y, et al (2011). Human hepatic stem cell and maturational liver lineage biology. Hepatology, 53, 1035-45.
DOI
|
11 |
van der Gun BT, Melchers LJ, Ruiters MH, et al (2010). EpCAM in carcinogenesis: the good, the bad or the ugly. Carcinogenesis, 31, 1913-21.
DOI
|
12 |
Verna L, Whysner J, Williams GM (1996). N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacol Ther, 71, 57-81.
DOI
|
13 |
Visvader JE, Lindeman GJ (2008). Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer, 8, 755-68.
DOI
ScienceOn
|
14 |
Wicha MS, Liu S, Dontu G (2006). Cancer stem cells: an old idea--a paradigm shift. Cancer Res, 66, 1883-1890; discussion 1895-86.
DOI
ScienceOn
|
15 |
Yamashita T, Forgues M, Wang W, et al (2008). EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res, 68, 1451-61.
DOI
|
16 |
Yamashita T, Ji J, Budhu A, et al (2009). EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology, 136, 1012-24.
DOI
|
17 |
Yoon SM, Gerasimidou D, Kuwahara R, et al (2011). Epithelial cell adhesion molecule (EpCAM) marks hepatocytes newly derived from stem/progenitor cells in humans. Hepatology, 53, 964-73.
DOI
|